Bard is acquiring Lutonix for $225 million in cash plus an additional $100 million based on FDA approval of a PMA for Lutonix's Moxy Drug-Coated Balloon

Lutonix Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

C.R. Bard Inc.

U.S. / Medical Devices and Diagnostics

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed